Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Article in press
DOI
PMC
 |
Open Access Hybrid |
|
as soon as is submitted to ZB.
Corrigendum to Candidate anti-tuberculosis medicines and regimens under clinical evaluation.
Clin. Microbiol. Infect. 32, 199-199 (2025)
The authors regret that the following text on funding of this work was not included: This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101007873. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA, Deutsches Zentrum für Infektionsforschung e. V. (DZIF), and Ludwig-Maximilians-Universität München (LMU). EFPIA/AP contribute to 50% of funding, whereas the contribution of DZIF and the LMU University Hospital Munich has been granted by the German Federal Ministry of Education and Research. The authors would like to apologise for any inconvenience caused.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Other: Correction, Addition
ISSN (print) / ISBN
1198-743X
e-ISSN
1469-0691
Quellenangaben
Volume: 32,
Issue: 1,
Pages: 199-199
Publisher
Wiley
Reviewing status
Peer reviewed
Institute(s)
Research Unit Global Health (UGH)